W.H. Cornerstone Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,438
Closed -$385K 129
2023
Q1
$385K Sell
9,438
-15,017
-61% -$649K 0.35% 78
2022
Q4
$1.17M Buy
24,455
+1,045
+4% +$50.1K 1.11% 26
2022
Q3
$981K Buy
+23,410
New +$1.14M 1.03% 29

Other funds holding PFE

W.H. Cornerstone Investments's PFE Position: Q2 2023 in Review

W.H. Cornerstone Investments sold out of Pfizer (PFE) in Q2 2023, closing a stake of 9,438 shares — an estimated $385K sold.

W.H. Cornerstone Investments first reported a position in PFE in Q3 2022 and held it in 3 quarters. The position peaked at $1.17M in Q4 2022. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • W.H. Cornerstone Investments reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • W.H. Cornerstone Investments sold 9,438 Pfizer shares in Q2 2023, an estimated $385K.
  • W.H. Cornerstone Investments first reported a position in Pfizer in Q3 2022 and held it in 3 quarters.
  • W.H. Cornerstone Investments's Pfizer position peaked at $1.17M in Q4 2022.
  • 3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on W.H. Cornerstone Investments's 13F filing for Q2 2023, filed 12 Jul 2023.